Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed1
Terminated1

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT04041128Early Phase 1Completed
PARP Inhibition During Pre-surgical Window in Breast/Ovary Cancer
Breast CancerOvarian Cancer
PrincipalinvestigatorStart date: 2019-07-23
NCT01535157Phase 1/2Terminated
Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer
Cancer of OvaryCancer of the OvaryOvarian Cancer+2 more
StudychairStart date: 2012-02-01

Research Network

Collaboration Network

6 collaborators·5 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of Texas Southwestern Medical Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Barry J Maurer, MD, PhD

Texas Tech University Health Sciences Center

Moderately Similar
2 trials

Shared therapeutic areas:

Ovary CancerOvarian NeoplasmsPrimary Peritoneal Carcinoma

Worked with same sponsors:

South Plains Oncology Consortium
Collaborated on 1 trial
Similarity Score34%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Breast CancerOvary Cancer
Similarity Score15%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Breast CancerOvary Cancer
Similarity Score15%

Steven A. Rosenberg, MD, PhD

NCI - Surgery Branch

Related
29 trials

Shared therapeutic areas:

Ovary CancerBreast Cancer
Similarity Score15%

Tim F Greten, M.D.

National Cancer Institute (NCI)

Related
22 trials

Shared therapeutic areas:

Ovary CancerOvarian Neoplasms
Similarity Score15%

Barbara B Biesecker

National Human Genome Research Institute (NHGRI)

Related
23 trials

Shared therapeutic areas:

Breast CancerOvarian Neoplasms
Similarity Score15%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Breast CancerOvary Cancer
Similarity Score15%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Breast CancerOvary Cancer
Similarity Score15%

Mark Levine, MD

Ontario Clinical Oncology Group (OCOG)

Related
13 trials

Shared therapeutic areas:

Breast CancerOvary Cancer
Similarity Score15%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Breast CancerOvary Cancer
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04041128Early Phase 1PrincipalInvestigator

PARP Inhibition During Pre-surgical Window in Breast/Ovary Cancer

Breast CancerOvarian Cancer
Completed
NCT01535157Phase 1/2StudyChair

Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer

Cancer of OvaryCancer of the OvaryOvarian Cancer+2 more
Terminated

All 2 trials loaded